ABSTRACT
Alzheimer's disease (AD) is the most common and devastating neurodegenerative condition worldwide, characterized by the aggregation of amyloid-ß and phosphorylated tau protein, and is accompanied by a progressive loss of learning and memory. A healthy nervous system is endowed with synaptic plasticity, among others neural plasticity mechanisms, allowing structural and physiological adaptations to changes in the environment. This neural plasticity modification sustains learning and memory, and behavioral changes and is severely affected by pathological and aging conditions, leading to cognitive deterioration. This article reviews critical aspects of AD neurodegeneration as well as therapeutic approaches that restore neural plasticity to provide functional recoveries, including environmental enrichment, physical exercise, transcranial stimulation, neurotrophin involvement, and direct electrical stimulation of the amygdala. In addition, we report recent behavioral results in Octodon degus, a promising natural model for the study of AD that naturally reproduces the neuropathological alterations observed in AD patients during normal aging, including neuronal toxicity, deterioration of neural plasticity, and the decline of learning and memory.
Subject(s)
Activities of Daily Living/psychology , Alzheimer Disease/psychology , Alzheimer Disease/therapy , Neuronal Plasticity/physiology , Neurons/physiology , Recovery of Function/physiology , Alzheimer Disease/physiopathology , Animals , Exercise/physiology , Exercise/psychology , Humans , Transcranial Direct Current Stimulation/methods , Transcranial Direct Current Stimulation/psychologyABSTRACT
Huntington's disease (HD) is an inherited, neurodegenerative disorder that results from the degeneration of striatal neurons, mainly GABAergic neurons. The study of neurochemical activity has provided reliable markers to explain motor disorders. To treat neurodegenerative diseases, stem cell transplants with bone marrow (BM) have been performed for several decades. In this work we determine the effect of mononuclear bone marrow cell (mBMC) transplantation on the rotational behavior and neurochemical activity in a model of Huntington's disease in rats. Four experimental groups were organized: Group I: Control animals (n = 5); Group II: Lesion with quinolinic acid (QA) in the striatum (n = 5); Group III: Lesion with QA and transplant with mBMC (n = 5); Group IV: Lesion with QA and transplant with culture medium (Dulbecco's modified Eagle's medium (DMEM) injection) (n = 5). The rotational activity induced by D-amphetamine was evaluated and the concentration of the neurotransmitter amino acids (glutamate and GABA) was studied. The striatal cell transplantation decreases the rotations induced by D-amphetamine (p < 0.04, Wilcoxon matched pairs test) and improves the changes produced in the levels of neurotransmitters studied. This work suggests that the loss of GABAergic neurons in the brain of rats lesioned with AQ produces behavioral and neurochemical alterations that can be reversed with the use of bone marrow mononuclear cell transplants.
ABSTRACT
Many training programs have been designed using modern software to restore the impaired cognitive functions in patients with acquired brain damage (ABD). The objective of this study was to evaluate the effectiveness of a computer-based training program of attention and memory in patients with ABD, using a two-armed parallel group design, where the experimental group (n = 50) received cognitive stimulation using RehaCom software, and the control group (n = 30) received the standard cognitive stimulation (non-computerized) for eight weeks. In order to assess the possible cognitive changes after the treatment, a post-pre experimental design was employed using the following neuropsychological tests: Wechsler Memory Scale (WMS) and Trail Making test A and B. The effectiveness of the training procedure was statistically significant (p < 0.05) when it established the comparison between the performance in these scales, before and after the training period, in each patient and between the two groups. The training group had statistically significant (p < 0.001) changes in focused attention (Trail A), two subtests (digit span and logical memory), and the overall score of WMS. Finally, we discuss the advantages of computerized training rehabilitation and further directions of this line of work.
ABSTRACT
BACKGROUND: Erythropoietin (EPO) upregulates the mitogen activated protein kinase (MAPK) cascade, a central signaling pathway in cellular plastic mechanisms, and is critical for normal brain development. OBJECTIVE: We hypothesized that EPO could modulate the plasticity mechanisms supporting spatial memory recovery in fimbria-fornix-transected animals. METHODS: Fimbria-fornix was transected in 3 groups of rats. Seven days later, EPO was injected daily for 4 consecutive days within 10 minutes after training on a water maze task. RESULTS: Our results show that EPO injections 10 minutes after training produced a substantial spatial memory recovery in fimbria-fornix-lesioned animals. In contrast, an EPO injection shortly after fimbria-fornix lesion surgery does not promote spatial-memory recovery. Neither does daily EPO injection 5 hours after the water maze performance. EPO, on the other hand, induced the expression of plasticity-related genes like arc and bdnf, but this effect was independent of training or lesion. CONCLUSIONS: This finding supports our working hypothesis that EPO can modulate transient neuroplastic mechanisms triggered by training in lesioned animals. Consequently, we propose that EPO administration can be a useful trophic factor to promote neural restoration when given in combination with training.
Subject(s)
Erythropoietin/therapeutic use , Fornix, Brain/injuries , Memory Disorders/drug therapy , Neuronal Plasticity/drug effects , Recovery of Function/drug effects , Analysis of Variance , Animals , Apoptosis Regulatory Proteins/genetics , Apoptosis Regulatory Proteins/metabolism , Brain Injuries/complications , Brain Injuries/pathology , Brain-Derived Neurotrophic Factor/genetics , Brain-Derived Neurotrophic Factor/metabolism , Disease Models, Animal , Fornix, Brain/pathology , Gene Expression Regulation/drug effects , Hemoglobins/metabolism , Male , Maze Learning/drug effects , Memory Disorders/etiology , Muscle Proteins/genetics , Muscle Proteins/metabolism , Rats , Rats, Wistar , Time FactorsABSTRACT
INTRODUCCIÓN: la Ataxia Espinocerebelosa tipo 2 (SCA2) es una enfermedad neurodegenerativa severa que representa un serio problema de salud en Cuba, debido a las altas tasas de prevalencia e incidencia y a la ausencia de tratamientos curativos. OBJETIVOS: evaluar el efecto y la seguridad del tratamiento con altas dosis de vitaminas del complejo B (Compvit-B) sobre la neuropatía periférica en pacientes con SCA2. MÉTODOS: se realizó una investigación prospectiva de intervención clínica en 20 enfermos en estadio ligero los que se sometieron a un protocolo terapéutico mediante la administración intramuscular del COMPVIT B por 12 semanas. Durante las primeras 4 semanas los individuos recibieron dos bulbos semanales y a partir de la 5tasemana un solo bulbo. Inmediatamente antes y después del tratamiento los pacientes fueron evaluados mediantes exámenes clínicos y electrofisiológicos. RESULTADOS: una vez concluido el tratamiento, los pacientes mostraron un aumento significativo de las amplitudes de los potenciales de acción sensitivos de nervios mediano y sural, y en este último nervio se observó además reducción de la latencia y aumento de la velocidad de conducción. Los parámetros de la conducción nerviosa motora no se modificaron. Los potenciales evocados somatosensoriales de nervio mediano arrojaron una reducción significativa de la latencia del potencial de Erb. De manera interesante se observó una la disminución significativa de la frecuencia de aparición de las contracturas musculares dolorosas en el 53% de los casos después del tratamiento. Durante el estudio no se registraron eventos adversos. CONCLUSIONES: el presente estudio identifica una nueva opción terapéutica sintomática en la SCA2, brinda nuevas evidencias sobre las bases fisiopatológicas y el manejo clínico de las contracturas musculares dolorosas y justifican la realización de estudios más amplios en pacientes y portadores de la mutación, los que presentan tales manifestaciones muchos antes de debutar con la ataxia.
INTRODUCTION: Spinocerebellar ataxia type 2 (SCA2) is a severe neurodegenerative disease which constitutes a serious health problem in Cuba due to its high prevalence and incidence rates and the lack of curative treatments. OBJECTIVES: Evaluate the effect and safety of the treatment with high doses of B-complex vitamins (Compvit-B) on peripheral neuropathy in patients with SCA2. METHODS: A prospective clinical intervention study was conducted of 20 patients in the mild stage of the disease undergoing a therapeutic protocol consisting in intramuscular injection of Compvit-B for 12 weeks. Patients were administered two ampoules weekly in the first 4 weeks and one from the fifth week onwards. Immediately before and after the treatment patients underwent clinical and electrophysiological examination. RESULTS: Upon completion of the treatment patients showed a significant increase in the amplitude of the sensitive action potentials of the median and sural nerves. In the latter case there was also a decrease in latency and an increase in conduction velocity. Motor nerve conduction parameters were not modified. Somatosensory evoked potentials of the median nerve showed a significant reduction in the latency of Erb's potential. A significant decrease was also found in the frequency of painful muscle contractures in 53% of the cases after treatment. Adverse events were not recorded during the study. CONCLUSIONS: The study identifies a new therapeutic option for symptomatic SCA2, and provides new evidence of the pathophysiological bases and clinical management of painful muscle contractures. Broader studies should be conducted with patients and carriers of the mutation, who typically present such manifestations long before developing ataxia.
Subject(s)
Humans , Vitamin B Complex/therapeutic use , Paraneoplastic Polyneuropathy , Spinocerebellar Ataxias , Prospective Studies , CubaABSTRACT
INTRODUCCIÓN: la ataxia Espinocerebelosa tipo 2 (SCA2) es una enfermedad neurodegenerativa que alcanza las mayores tasas de prevalencia e incidencia en Holguín, Cuba. Una de las principales manifestaciones clínicas de estos pacientes son los trastornos cognitivos, expresados fundamentalmente como déficits frontoejecutivos y de la memoria. OBJETIVO: evaluar el efecto del tratamiento con vitaminas del Complejo B sobre las funciones cognitivas, en pacientes cubanos con SCA2. MÉTODOS: se incluyeron 20 pacientes en una investigación de intervención clínica, empleando COMPVIT-B, durante 3 meses. Se evaluaron parámetros clínicos, como la escala SARA y cognitivos como el test de Stroop, el test de Fluencia verbal fonológica y el test de memoria verbal. Todos los estudios se realizaron antes y después del tratamiento. RESULTADOS: el estudio de las funciones frontoejecutivas reveló un aumento significativo del número de palabras mencionadas en el test de fluencia verbal fonológica, al terminar el estudio. Sin embargo, el test de Stroop no mostró cambios significativos. En relación al test de memoria verbal, se obtuvo un aumento del número de palabras recordadas en el primer ensayo, así como reducción del número de ensayos requeridos para recordar todas las palabras. La puntuación de la escala SARA no cambió significativamente. CONCLUSIONES: el presente trabajo constituye una evidencia adicional en favor del uso terapéutico y neuroprotector de las vitaminas del complejo B e identifica una nueva opción de tratamiento sintomatológico para los enfermos con SCA2, lo que incide positivamente en el mejoramiento de la calidad de vida de estos pacientes.
INTRODUCTION: Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease with the highest prevalence and incidence rates in the province of Holguín, Cuba. One of its main clinical manifestations is cognitive disorders, fundamentally expressed as frontal-executive and memory deficits. OBJECTIVE: Evaluate the effect of B-complex vitamins on cognitive functions in Cuban patients with SCA2. METHODS: Twenty patients were included in a clinical intervention study based on the use of Compvit-B for 3 months. An evaluation was conducted of clinical parameters such as the Scale for the Assessment and Rating of Ataxia (SARA), and cognitive parameters like the Stroop test, the phonological verbal fluency test and the verbal memory test. All the studies were conducted before and after the treatment. RESULTS: The study of frontal-executive functions revealed a significant increase in the number of words mentioned in the phonological verbal fluency test at the end of the study. However, the Stroop test did not show any significant change. The verbal memory test showed an increase in the number of words recalled in the first assay, and a reduction in the number of assays required to recall all the words. Scores on the SARA did not change significantly. CONCLUSIONS: The paper provides additional evidence in support of the therapeutic and neuroprotective use of B-complex vitamins and presents a new option of symptomatic treatment for patients with SCA2, which will lead to an improvement in their quality of life.
Subject(s)
Humans , Vitamin B Complex/therapeutic use , Cognition Disorders/ethnology , Spinocerebellar Ataxias , CubaABSTRACT
Introducción: la Ataxia Espinocerebelosa tipo 2 (SCA2) es una enfermedad neurodegenerativa severa que representa un serio problema de salud en Cuba, debido a las altas tasas de prevalencia e incidencia y a la ausencia de tratamientos curativos. Objetivos: evaluar el efecto y la seguridad del tratamiento con altas dosis de vitaminas del complejo B (Compvit-B) sobre la neuropatía periférica en pacientes con SCA2. Métodos: se realizó una investigación prospectiva de intervención clínica en 20 enfermos en estadio ligero los que se sometieron a un protocolo terapéutico mediante la administración intramuscular del COMPVIT B por 12 semanas. Durante las primeras 4 semanas los individuos recibieron dos bulbos semanales y a partir de la 5ta semana un solo bulbo. Inmediatamente antes y después del tratamiento los pacientes fueron evaluados mediantes exámenes clínicos y electrofisiológicos. Resultados: una vez concluido el tratamiento, los pacientes mostraron un aumento significativo de las amplitudes de los potenciales de acción sensitivos de nervios mediano y sural, y en este último nervio se observó además reducción de la latencia y aumento de la velocidad de conducción. Los parámetros de la conducción nerviosa motora no se modificaron. Los potenciales evocados somatosensoriales de nervio mediano arrojaron una reducción significativa de la latencia del potencial de Erb. De manera interesante se observó una la disminución significativa de la frecuencia de aparición de las contracturas musculares dolorosas en el 53 por ciento de los casos después del tratamiento. Durante el estudio no se registraron eventos adversos...
Introduction: Spinocerebellar ataxia type 2 (SCA2) is a severe neurodegenerative disease which constitutes a serious health problem in Cuba due to its high prevalence and incidence rates and the lack of curative treatments. Objectives: Evaluate the effect and safety of the treatment with high doses of B-complex vitamins (Compvit-B) on peripheral neuropathy in patients with SCA2. Methods: A prospective clinical intervention study was conducted of 20 patients in the mild stage of the disease undergoing a therapeutic protocol consisting in intramuscular injection of Compvit-B for 12 weeks. Patients were administered two ampoules weekly in the first 4 weeks and one from the fifth week onwards. Immediately before and after the treatment patients underwent clinical and electrophysiological examination. Results: Upon completion of the treatment patients showed a significant increase in the amplitude of the sensitive action potentials of the median and sural nerves. In the latter case there was also a decrease in latency and an increase in conduction velocity. Motor nerve conduction parameters were not modified. Somatosensory evoked potentials of the median nerve showed a significant reduction in the latency of Erb's potential. A significant decrease was also found in the frequency of painful muscle contractures in 53 percent of the cases after treatment. Adverse events were not recorded during the study...
Subject(s)
Humans , Spinocerebellar Ataxias/drug therapy , Paraneoplastic Polyneuropathy/drug therapy , Vitamin B Complex/therapeutic use , Prospective Studies , CubaABSTRACT
Introducción: la ataxia Espinocerebelosa tipo 2 (SCA2) es una enfermedad neurodegenerativa que alcanza las mayores tasas de prevalencia e incidencia en Holguín, Cuba. Una de las principales manifestaciones clínicas de estos pacientes son los trastornos cognitivos, expresados fundamentalmente como déficits frontoejecutivos y de la memoria. Objetivo: evaluar el efecto del tratamiento con vitaminas del Complejo B sobre las funciones cognitivas, en pacientes cubanos con SCA2. Métodos: se incluyeron 20 pacientes en una investigación de intervención clínica, empleando COMPVIT-B, durante 3 meses. Se evaluaron parámetros clínicos, como la escala SARA y cognitivos como el test de Stroop, el test de Fluencia verbal fonológica y el test de memoria verbal. Todos los estudios se realizaron antes y después del tratamiento. Resultados: el estudio de las funciones frontoejecutivas reveló un aumento significativo del número de palabras mencionadas en el test de fluencia verbal fonológica, al terminar el estudio. Sin embargo, el test de Stroop no mostró cambios significativos. En relación al test de memoria verbal, se obtuvo un aumento del número de palabras recordadas en el primer ensayo, así como reducción del número de ensayos requeridos para recordar todas las palabras. La puntuación de la escala SARA no cambió significativamente. Conclusiones: el presente trabajo constituye una evidencia adicional en favor del uso terapéutico y neuroprotector de las vitaminas del complejo B e identifica una nueva opción de tratamiento sintomatológico para los enfermos con SCA2, lo que incide positivamente en el mejoramiento de la calidad de vida de estos pacientes(AU)
Introduction: Spinocerebellar ataxia type 2 (SCA2) is a neurodegenerative disease with the highest prevalence and incidence rates in the province of HolguÝn, Cuba. One of its main clinical manifestations is cognitive disorders, fundamentally expressed as frontal-executive and memory deficits. Objective: Evaluate the effect of B-complex vitamins on cognitive functions in Cuban patients with SCA2. Methods: Twenty patients were included in a clinical intervention study based on the use of Compvit-B for 3 months. An evaluation was conducted of clinical parameters such as the Scale for the Assessment and Rating of Ataxia (SARA), and cognitive parameters like the Stroop test, the phonological verbal fluency test and the verbal memory test. All the studies were conducted before and after the treatment. Results: The study of frontal-executive functions revealed a significant increase in the number of words mentioned in the phonological verbal fluency test at the end of the study. However, the Stroop test did not show any significant change. The verbal memory test showed an increase in the number of words recalled in the first assay, and a reduction in the number of assays required to recall all the words. Scores on the SARA did not change significantly. Conclusions: The paper provides additional evidence in support of the therapeutic and neuroprotective use of B-complex vitamins and presents a new option of symptomatic treatment for patients with SCA2, which will lead to an improvement in their quality of life(AU)
Subject(s)
Humans , Spinocerebellar Ataxias/drug therapy , Vitamin B Complex/therapeutic use , Cognition Disorders/etiology , CubaABSTRACT
Se realizó un estudio experimental controlado a doble ciegas para comprobar la efectividad atribuida a las llamadas esencias florales de Bach para mejorar las funciones de memoria. Para ello se administró una mezcla de 5 flores (Chestnut Bud, Red Chestnut, Wild Oat, Honey Suckle y Clematis) obtenidas de la Farmacia Homeopática (23 esq. a M, Vedado La Habana) a estudiantes de 1er año de la Universidad de La Habana. Se constituyeron 3 grupos, uno sin tratamiento y los otros dos que recibieron 4 aplicaciones diarias durante 10 días de 4 gotas sublinguales de la mezcla floral o un placebo que fue el vehículo en que se preparan y conservan las flores. Para evaluar el efecto aludido se aplicó a todos los participantes un test de memoria (test de Rey) en días sucesivos. En el primer día les fue presentada una lista de 15 palabras y se recogió por escrito la cantidad de palabras correctas que fueron capaces de evocar de forma inmediata. Este procedimiento se repitió 5 veces y se notó un incremento progresivo en el número de aciertos. Al día siguiente se les entregó una historieta escrita que contenía, dispersas entre otras, las 15 palabras de la lista y se le pidió subrayar las que pudieran identificar como pertenecientes a esa lista. El análisis estadístico de los resultados (ANOVA) no permitió identificar diferencias significativas entre los grupos en ninguna de las pruebas. Estos resultados no apoyan la hipótesis de que tales preparados ejerzan un efecto real y sugieren que su posible éxito en algunos casos es de tipo placebo(AU)
An experimental double blind controlled study was carried out to confirm the effectiveness of the so-called Bach flower essences in the improvement of memory functions. To this end, a five flower mixture (Chesnut, Bud, Red Chesnut, Wild Oat, Honey Suckle and Clematis) obtained from homeopathic drugstore located in Havana was administered to first-year university students at the University of Havana. Three groups were created, one without treatment and the two other groups received 4 daily doses for 10 days at a rate of 4 drops sublingually of the flower mixture or the placebo in which flower are prepared and preserved. To assess the effect, a memory test (Rey´s test) was applied to the participants in the subsequent days. The first day, they were given a list of 15 words and the number of correct words that they were able to remember immediately was recorded in writing. This method was repeated 5 times; there was a progressive increase in the number of correct words remembered. On the following day, they were given some cartoon story containing among other the 15 words from the list and the participants were asked to identify them. The Statistical analysis (ANOVA) of the results did not show significant differences among the groups in none of the tests. These results did not support the hypothesis that these flower mixtures have a real impact and suggested that their possible success in some cases be of placebo-type(AU)
Subject(s)
Humans , Homeopathy , Memory DisordersABSTRACT
Se realizó un estudio experimental controlado a doble ciegas para comprobar la efectividad atribuida a las llamadas esencias florales de Bach para mejorar las funciones de memoria. Para ello se administró una mezcla de 5 flores (Chestnut Bud, Red Chestnut, Wild Oat, Honey Suckle y Clematis) obtenidas de la Farmacia Homeopática (23 esq. a M, Vedado La Habana) a estudiantes de 1er año de la Universidad de La Habana. Se constituyeron 3 grupos, uno sin tratamiento y los otros dos que recibieron 4 aplicaciones diarias durante 10 días de 4 gotas sublinguales de la mezcla floral o un placebo que fue el vehículo en que se preparan y conservan las flores. Para evaluar el efecto aludido se aplicó a todos los participantes un test de memoria (test de Rey) en días sucesivos. En el primer día les fue presentada una lista de 15 palabras y se recogió por escrito la cantidad de palabras correctas que fueron capaces de evocar de forma inmediata. Este procedimiento se repitió 5 veces y se notó un incremento progresivo en el número de aciertos. Al día siguiente se les entregó una historieta escrita que contenía, dispersas entre otras, las 15 palabras de la lista y se le pidió subrayar las que pudieran identificar como pertenecientes a esa lista. El análisis estadístico de los resultados (ANOVA) no permitió identificar diferencias significativas entre los grupos en ninguna de las pruebas. Estos resultados no apoyan la hipótesis de que tales preparados ejerzan un efecto real y sugieren que su posible éxito en algunos casos es de tipo placebo.
An experimental double blind controlled study was carried out to confirm the effectiveness of the so-called Bach flower essences in the improvement of memory functions. To this end, a five flower mixture (Chesnut, Bud, Red Chesnut, Wild Oat, Honey Suckle and Clematis) obtained from homeopathic drugstore located in Havana was administered to first-year university students at the University of Havana. Three groups were created, one without treatment and the two other groups received 4 daily doses for 10 days at a rate of 4 drops sublingually of the flower mixture or the placebo in which flower are prepared and preserved. To assess the effect, a memory test (Rey´s test) was applied to the participants in the subsequent days. The first day, they were given a list of 15 words and the number of correct words that they were able to remember immediately was recorded in writing. This method was repeated 5 times; there was a progressive increase in the number of correct words remembered. On the following day, they were given some cartoon story containing among other the 15 words from the list and the participants were asked to identify them. The Statistical analysis (ANOVA) of the results did not show significant differences among the groups in none of the tests. These results did not support the hypothesis that these flower mixtures have a real impact and suggested that their possible success in some cases be of placebo-type.